[HTML][HTML] Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective

M Baumgart, HM Snyder, MC Carrillo, S Fazio… - Alzheimer's & …, 2015 - Elsevier
An estimated 47 million people worldwide are living with dementia in 2015, and this number
is projected to triple by 2050. In the absence of a disease-modifying treatment or cure …

Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence

M Hersi, B Irvine, P Gupta, J Gomes, N Birkett… - Neurotoxicology, 2017 - Elsevier
A systematic review was conducted to identify risk factors associated with the onset and
progression of Alzheimer's disease (AD). Moderate and high quality systematic reviews …

The projected effect of risk factor reduction on Alzheimer's disease prevalence

DE Barnes, K Yaffe - The Lancet Neurology, 2011 - thelancet.com
Summary At present, about 33· 9 million people worldwide have Alzheimer's disease (AD),
and prevalence is expected to triple over the next 40 years. The aim of this Review was to …

Body mass index in midlife and late‐life as a risk factor for dementia: a meta‐analysis of prospective studies

KJ Anstey, N Cherbuin, M Budge, J Young - Obesity reviews, 2011 - Wiley Online Library
The relationship between body mass index (BMI)(in midlife and late‐life) and dementia was
investigated in meta‐analyses of 16 articles reporting on 15 prospective studies. Follow‐ups …

Angiotensin II revisited: new roles in inflammation, immunology and aging

A Benigni, P Cassis, G Remuzzi - EMBO molecular medicine, 2010 - embopress.org
That the renin–angiotensin system (RAS) is involved in regulation of blood pressure,
vasoconstriction, sodium intake and potassium excretion is well established. Studies in the …

Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia

JC de La Torre - Cardiovascular psychiatry and neurology, 2012 - Wiley Online Library
Heart disease is the major leading cause of death and disability in the world. Mainly
affecting the elderly population, heart disease and its main outcome, cardiovascular …

Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses …

L Rouch, P Cestac, O Hanon, C Cool, C Helmer… - CNS drugs, 2015 - Springer
Background Chronic hypertension, particularly midlife high blood pressure, has been
associated with an increased risk for cognitive decline and dementia. In this context …

Cognitive function, dementia and type 2 diabetes mellitus in the elderly

MWJ Strachan, RM Reynolds, RE Marioni… - Nature Reviews …, 2011 - nature.com
Increasing numbers of people are developing type 2 diabetes mellitus, but interventions to
prevent and treat the classic microvascular and macrovascular complications have …

Brain renin-angiotensin—a new look at an old system

JW Wright, JW Harding - Progress in neurobiology, 2011 - Elsevier
The classic renin-angiotensin system (RAS) is described as a circulating hormone system
focused on cardiovascular and body water regulation, with angiotensin II as its major …

The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases

JW Wright, JW Harding - Pflügers Archiv-European Journal of Physiology, 2013 - Springer
The classic renin–angiotensin system (RAS) was initially described as a hormone system
designed to mediate cardiovascular and body water regulation, with angiotensin II as its …